Oral isotretinoin – indications and limitations in the treatment of acne

Bartłomiej Kwiek; Andrzej Langner

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current Issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Ethical standards and procedures Reviewers Instructions for authors Publication charge

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2005
vol. 22

Send email

Copy url:

abstract:

Oral isotretinoin – indications and limitations in the treatment of acne

Bartłomiej Kwiek

,

Andrzej Langner

PDiA 2005; XXII, 3: 105–111

Online publish date: 2005/06/23

View full text Get citation

Acne is one of the most common skin disorder. Systemic isotretinoin is the treatment of choice in the most severe forms of this disease. We present an overview of mechanisms of isotretinoin in the pathogenesis of acne and current guidelines on indications and dosage with more detailed description of potential adverse events.

keywords:

Oral isotretinoin – indications and limitations in the treatment of acne

Bartłomiej Kwiek , Andrzej Langner

isotretinoin, acne, adverse events

Bartłomiej Kwiek

,

Andrzej Langner